|
|
Diethylstilbestrol (DES) is a drug once prescribed during pregnancy to
prevent miscarriages or premature deliveries. In the U.S. an estimated 5 to
10 million persons were exposed to DES from 1938 to 1971, including
pregnant women prescribed DES and their children. In 1971, the Food and
Drug Administration (FDA) advised physicians to stop prescribing DES
because it was linked to a rare vaginal cancer.
After more than 30 years of research, there are confirmed health risks associated with DES
exposure. However, not all exposed individuals will experience
DES-related health problems. Whether you know for sure or suspect you
were exposed to DES, you can use CDC's DES Update to learn more about DES
exposure and what you can do about it.
|
|
|
|
DES
Spotlight's |
|
|
|
|
CDC’s DES Update Campaign Wins More Awards
CDC’s DES Update Campaign was honored
this year with two ASTRID awards and
one Mercury award. These awards are given
out by MerComm Inc. MerComm was founded in 1987
for the purpose of advancing the arts and
sciences of communications in an international
arena. It strives to establish and promote high
standards of individual and collective
achievement. Two of the awards they give out are
the ASTRID and the Mercury awards.
The ASTRID Award “serves as a showcase for
excellence in design” and was founded in 1991.
It is given in an International Competition
Honoring Outstanding Achievement in Design
Communications. The ASTRID awards are one of the
largest awards in the world. The Mercury Award
is given in an International Competition
honoring Outstanding Achievement in Professional
Communications.
CDC’s DES Update won the 2004 Bronze ASTRID
award for the Health Care Provider CD-ROM and
Honors for the Consumer Binder. CDC’s DES Update
won the Honors Mercury Award in the Public
Health Awareness Campaign Category.
We would like to acknowledge all of our partners
who were instrumental in the development of the
health education campaign.
|
|
|
|
|
|
For Consumers
Helpful information on DES research and a guide to help assess whether you might have been exposed to DES, as well as in-depth information for women prescribed DES while pregnant and their DES Daughters and DES Sons.
|
|
|
|
|
|
For Health Care Providers
Resources to help identify and counsel DES-exposed individuals. Material includes essential facts for clinicians and nurses, pharmacology, NCI guidelines, educational tools and resources, and support organizations.
|
|
|
|
|
|
For DES Update Partners
Tools to help you share information from the DES Update with your organization, including promotional materials, Web site linking kit, fact sheets and newsletter articles.
|
|
|
|
|
|